Finding a Balanced Strategy in Prostate Cancer Diagnosis for Case Detection by Prostate Needle Biopsy at First Presentation: "All for More Cores and More Cores for All" or Individualised Sampling Regimens? Which Way Forward?

European Urology

Volumn 52, Issue 2, 2007, Pages 313-315

  Patel, Anup ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER PATIENT; CANCER SURVIVAL; DIGITAL RECTAL EXAMINATION; EDITORIAL; HUMAN; MORBIDITY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RISK ASSESSMENT; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY;

BIOPSY, NEEDLE; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 34250778932     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.03.031     Document Type: Editorial

References (10)

1. Thompson I.M., Pauler D.K., Goodman P.J., et al. Prevalence of prostate cancer among men with a prostate specific antigen level ≤4 ng per milliliter. N Eng J Med 350 (2004) 2239-2246
2. Hodge K.K., McNeal J.E., and Terris M.K. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142 (1989) 71-74 discussion 75
3. Guichard G., Larré S., Gallina A., et al. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients. Eur Urol. 52 (2007) 430-435
4. Jones J.S., Patel A., Schoenfield L., et al. Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol 175 (2006) 485-488
5. Draisma G., Boer R., Otto S.J., et al. Lead times and over-detection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 95 (2003) 868-878
6. Stamey T.A., Caldwell M., McNeal J.E., et al. The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?. J Urol 172 (2004) 1297-1301
7. Remzi M., Fong Y.K., Dobrovits M., et al. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol 174 (2005) 1256-1261
8. Carter H.B., Ferrucci L., Kettermann A., et al. Detection of life threatening prostate cancer with prostate specific antigen velocity during a window of curability. J Natl Cancer Inst 98 (2006) 1521-1527
9. Laniado M.E., McMullen L., Walker M.M., and Patel A. Use and rationale of a multicompartment microcassette for site-specific biopsies of the prostate in a consecutive cohort of men. Prostate Cancer Prostatic Dis 6 (2003) 50-52
10. Boccon-Gibod L.M., de Longchamps N.B., Toublanc M., et al. Prostate saturation biopsy in the re-evaluation of microfocal prostate cancer. J Urol 176 (2006) 961-963 discussion 963-4